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Anti-p200 pemphigoid is an autoimmune subepidermal
blistering disease characterized by autoantibodies to a
200-kDa protein (p200) of the dermal^epidermal junc-
tion (DEJ). p200 has been demonstrated to be distinct
from all major DEJ autoantigens and is thought to be
important for cell-matrix adhesion.This study provides
the ¢rst biochemical characterization of p200. Di¡eren-
tial extraction experiments demonstrated that e⁄cient
recovery of p200 from the dermis was strongly depen-
dent on the presence of reducing agents, suggesting that
it forms highly insoluble oligomers and/or is exten-
sively cross-linked to other extracellular matrix com-
ponents by disul¢de bonding. p200 was resistant to
digestion with bacterial collagenase, whereas this treat-
ment did degrade major collagenous proteins of the
dermis, including type I, VI, and VII collagen. This
¢nding ¢rmly established the noncollagenous nature of
p200. N-Glycosidase F reduced the molecular size of the
p200 autoantigen from 200 to 190 kDa without decreas-
ing its immunoreactivity. In contrast, digestion of p200
with neuraminidase,O-glycosidase, chondroitinase ABC,
and heparitinase I had no e¡ect on its electrophoretic
mobility. These data suggest that the p200 molecule
contains N-glycans but lacks O-linked oligosaccharides
and chondroitin/heparan sulfate side chains. Two-di-
mensional gel electrophoresis demonstrated that p200 is
an acidic protein with an isoelectric point of 5.4 to 5.6.
Six di¡erent p200-speci¢c sera recognized an identical
protein spot of two-dimensionally separated dermal ex-
tracts, con¢rming that patients with this novel autoim-
mune disease indeed form a single pathobiochemical
entity. Key words: autoantibody/collagen/dermal^epidermal
junction/glycosylation/two-dimensional gel electrophoresis. J
Invest Dermatol 121:1402 ^1408, 2003
A
nti-p200 pemphigoid is an autoimmune subepi-
dermal blistering disease ¢rst described in 1996
(Zillikens et al, 1996; Chen et al, 1996). Immuno-
pathologically, it is characterized by linear deposits
of IgG and C3 along the dermal^epidermal junc-
tion (DEJ) as detected by direct immuno£uorescence microscopy
of perilesional skin biopsies. Indirect immuno£uorescence of pa-
tients’ sera demonstrates circulating IgG autoantibodies labeling
the dermal side of NaCl-split normal skin. The antigenic target
of these antibodies is a 200-kDa protein (p200) of the human
dermis that is thought to be important for cell-matrix adhesion
(Zillikens et al, 1996; Kawahara et al, 2000). Ultrastructural studies
localized p200 to the lower portion of the lamina lucida of the
cutaneous basement membrane (Zillikens et al, 1996; Chen et al,
1996; Egan et al, 2002).While p200 was demonstrated to be im-
munologically distinct from all major autoantigens of the DEJ,
including bullous pemphigoid (BP) antigens 180 and 230, a6b4
integrin, laminin 5 and 6, and type VII collagen (Zillikens et al,
1996, 2000; Kawahara et al, 2000), little is known about its struc-
ture and biochemical properties. In this study, we investigate the
association of p200 with the extracellular matrix (ECM) and the
presence of collagenous domains and carbohydrate moieties
within this molecule. In addition, we demonstrate that IgG4
autoantibodies from six patients with anti-p200 pemphigoid re-
cognize the same unique protein of two-dimensionally separated
dermal extracts.
MATERIALS ANDMETHODS
Patient and rabbit sera and monoclonal antibodies In this study, we
used sera from six patients with anti-p200 pemphigoid. Four of these
patients have been described in detail elsewhere (Zillikens et al, 1996, 2000;
Mascaro et al, 2000; Egan et al, 2002). All patients ful¢lled the following
criteria: (1) linear deposits of IgG and C3 along the DEJ as detected by
direct immuno£uorescence of perilesional skin biopsies; (2) linear
deposition of IgG along the dermal side of NaCl-split normal human
skin by indirect immuno£uorescence microscopy; and (3) circulating
antibodies against a 200-kDa protein by immunoblotting of extracts of
normal human dermis. Rabbit antibodies to human type I and type VI
collagen were purchased from Rockland (Gilbertsville, PA). Rabbit serum
to human proteoglycan I (biglycan) was provided by H. Kresse (Mˇnster,
Germany). Rabbit serum SA8010 was raised against recombinant BP180
NC16A (Sitaru et al, 2002). Monoclonal antibodies 1A8c and BM515 were
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raised against BP180 and the a3 chain of laminin 5, respectively (Hirako
et al, 1996, 2003). Monoclonal antibody LH7.2 against the NC1 domain of
type VII collagen was purchased from Sigma (St. Louis, MO) and
monoclonal antibody A1 against the g1 chain of laminin 1 was from
Neomarkers (Fremont, CA). For the experiments conducted, we obtained
institutional approval (Institutional Board Project # 37/98) issued by the
director of the ethics committee at the Medical Faculty of the University
of Wuerzburg. We obtained informed consent from all patients whose
material was used in the study, in adherence to the Helsinki Principles.
Immunoblotting and determination of subclass distribution of
p200-speci¢c autoantibodies Immunoblotting of dermal extracts and
other substrates was performed as described previously (Zillikens et al,
1996). Unless otherwise speci¢ed, all immunoblotting studies with serum
samples from patients with anti-p200 pemphigoid were performed using
anti-IgG4 secondary antibodies (see below). Subclass distribution of p200-
speci¢c autoantibodies was determined using peroxidase-conjugated
mouse anti-human IgG1 (clone 8c/6-39), antihuman IgG2 (clone HP6014),
anti-human IgG3 (clone HP6050), and anti-human IgG4 (clone HP6023)
(all from The Binding Site, Birmingham, UK) following a previously
published protocol (Chimanovitch et al, 1999). Sensitivities of these
secondary monoclonal antibodies, used at their working dilutions, had
been shown to be comparable by immunoblot analysis with equal
amounts of human myeloma proteins (Chimanovitch et al, 1999).
Preparation of dermal extracts, di¡erential extraction, and
solubility studies Fresh normal human skin was obtained from plastic
surgery and incubated in phosphate-bu¡ered saline, pH 7.2, supplemented
with 1 M NaCl, 1 mM phenylmethylsulfonyl £uoride (PMSF), and 5 mM
ethylenediaminetetraacetic acid (EDTA) at 41C for 96 h. After dermal^
epidermal separation, the epidermis was peeled o¡ and discarded. The
epidermal surface of the dermis was extensively washed with phosphate-
bu¡ered saline and extracted with bu¡er A (12.5 mM Tris-HCl, pH 7.0, 8
M urea, 6% b-mercaptoethanol, 1 mM PMSF, and 5 mM EDTA) at room
temperature. After 1 h, the dermal extract was collected and centrifuged,
and the supernatant was stored at ^801C. For di¡erential extraction
experiments, deepidermized dermis was prepared as described above
and then extracted with bu¡er B (same as bu¡er A but without
b-mercaptoethanol) followed by bu¡er A. For some experiments, the
epidermal surface of the dermis was digested with bacterial collagenase as
described below and subsequently extracted with bu¡ers B and A. To
determine the solubility of extracted protein, dermal extracts were
alkylated by addition of 100 mM iodoacetamide for 1 h in the dark and
subsequently dialyzed against 4, 2, or 1 M urea (all solutions bu¡ered with
50 mMTris-HCl, pH 7.5), RIPA bu¡er (50 mMTris-HCl, pH 7.5, 500 mM
NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS), or Tris-
bu¡ered saline (same as RIPA but without detergents), respectively.
Dialyzed extracts were centrifuged at 100,000 g for 2 h, and both
supernatants and pellets were analyzed for reactivity with anti-p200 sera
by immunoblotting.
Cell culture Normal keratinocytes and ¢broblasts were cultured from
outgrowing cells of human neonatal foreskins as described previously
(Zillikens et al, 1996). HaCaT keratinocytes were provided by N.E.
Fusenig (Heidelberg, Germany) and grown as described by Boukamp et al
(1988). Con£uent monolayers of keratinocytes or ¢broblasts were extracted
with Laemmli sample bu¡er (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 6%
b-mercaptoethanol) supplemented with 5 mM EDTA and 1 mM PMSF.
Extracts were pulse-sonicated on ice and centrifuged, and the supernatant
was collected. Proteins in the medium conditioned by HaCaT keratino-
cytes or ¢broblasts were concentrated by ammonium sulfate precipitation
as described (Kromminga et al, 2000). Cryosections of organotypic co-
cultures of human keratinocytes and ¢broblasts harvested at 3 wk (Smola
et al, 1998) were provided by N.E. Fusenig.
Proteolytic digests Collagenase digestion was performed as described
by Giudice et al (1992) with some modi¢cation. Dermal extracts were
dialyzed against collagenase bu¡er (50 mM Tris-HCl, pH 7.5, 500 mM
NaCl, 10 mM CaCl2). Protease inhibitors (1 mM PMSF, 1 mM AEBSF,
10 mg/mL leupeptin, 10 mg/mL antipain, 15 mg/mL pepstatin A, 15 mg/mL
chymostatin) and 1 Mandl U/mL of collagenase from Clostridium
histolyticum (Amano Pharmaceuticals, Japan) were added to the dialysate,
and after incubation at 371C for various periods of time, the reaction was
stopped by addition of 5Laemmli sample bu¡er, containing 100 mM
EDTA, and boiling for 5 min. Negative controls included dermal extracts
incubated at 371C without collagenase and collagenase digestion of bovine
serum albumin (Sigma). For tissue digestion, collagenase bu¡er containing
protease inhibitors and 100 Mandl U per mL collagenase was applied to the
epidermal surface of deepidermized dermis and incubated at 371C 4 h. For
digestion with bacterial proteaseV8 (Glu-C), dermal extracts were dialyzed
against 0.01% SDS in 25 mM NH4HCO3 (pH 7.8) and protease V8 from
Staphylococcus aureus (Roche, Mannheim, Germany) was added at an
enzyme to substrate ratio of 1:100. After incubation at room temperature
for various periods of time, the reaction was stopped by addition of
5Laemmli sample bu¡er and boiling. The products of V8 digestion
were separated in 4% to 20% gradient gels (Bio-Rad, Hercules, CA) and
studied by immunoblotting.
Deglycosylation studies To investigate the presence of N-linked
carbohydrate moieties within the p200 molecule, dermal extracts were
dialyzed against 20 mM Na3PO4, pH 7.2, supplemented with 0.2% SDS,
1% b-mercaptoethanol, 15 mM EDTA and then denatured at 1001C for
5 min. After addition of 1% Nonidet P-40 and 300 U per mL recombinant
N-glycosidase F cloned from Flavobacterium meningosepticum (Roche), the
sample was incubated at 371C overnight. Bovine fetuin (Sigma) and
human transferrin (Roche) were used as positive controls. In contrast to
N-linked carbohydrates, O-linked oligosaccharides may be di⁄cult to
remove from a protein in one step. O-deglycosylation studies were
therefore performed by sequential treatment of dermal extracts ¢rst with
neuraminidase from Arthrobacter ureafaciens (400 mU/mL) and then
O-glycosidase from Diplococcus pneumoniae (200 mU/mL) at 371C for 12 h,
respectively (both enzymes from Roche). Deglycosylation of bovine fetuin
(Sigma), known to contain neuraminic acid and O-linked sugars, was used
as a positive control and monitored by Coomassie staining. Finally, to
assess the presence of chrondroitin sulfate and heparan sulfate side chains
in the p200 molecule, dermal extracts were digested with 4 U per mL
chondroitinase ABC from Proteus vulgaris (in 0.1 M Tris-HCl, pH 8.0,
containing 30 mM sodium acetate) or 100 mU per mL heparitinase I
from Flavobacterium heparinum (in 20 mM sodium acetate, pH 7.0,
containing 1 mM calcium acetate) at 371C overnight. Heparitinase was
from Seikagaku (Tokyo, Japan) and chondroitinase from Calbiochem
(Schwalbach, Germany). Heparan sulfate from bovine kidney (Sigma) was
used as a positive control for heparitinase digestion and the reaction was
monitored at 232 nm. Negative controls for all deglycosylation
experiments were incubated under identical conditions without addition
of glycosidases. All enzymes used were of protease-free quality.
Two-dimensional gel electrophoresis was performed as described by
O’Farrel (1975) with some modi¢cation. Dermal extracts were exhaustively
dialyzed against double-distilled water and precipitated protein pelleted by
centrifugation at 100,000 g for 1 h. The pellet was resuspended in 1/10
original volume of 2D sample bu¡er (9 M urea, 4% Triton X-100, 10% b-
mercaptoethanol, 2% ampholines 3.5^10 (Sigma)) and separated by
isoelectric focusing (¢rst dimension) using 125-mm 3% polyacrylamide
tube gels over 5000 Vh. After equilibration of the focused gels in
Laemmli sample bu¡er, they were loaded on 6% polyacrylamide gels and
subjected to SDS-PAGE (second dimension) in a xi electrophoresis cell
(Bio-Rad). The two-dimensionally separated dermal proteins were then
electrophoretically transferred to nitrocellulose membrane and probed
with p200-speci¢c antibodies.
N-terminal sequencing and mass spectrometry For N-terminal
sequencing, two-dimensionally separated dermal extracts were transferred
to polyvinylidenedi£uoride membrane and the immunoreactive spot was
analyzed using an ABI 492 CLC sequencing system (Applied Biosystems,
Foster City, CA) following the instructions of the manufacturer. Mass
spectrometry analysis was performed as described by Butt et al (2000).
Brie£y, the protein spot was excised from the gel and transferred to a
quartz vessel. Gel pieces were dehydrated under vacuum and soaked with
trypsin solution (0.05 mg/mL trypsin; Promega, Madison, WI). After
digestion, the peptides were extracted with 8 mL of 5% formic acid for
15 min in the sonication bath and analyzed using an ESI-ion trap mass
spectrometer (LCQ Classic, Thermo Finnigan, San Jose, CA) directly
coupled to a nano-HPLC system (LC-Packings, Dionex, Idstein,
Germany). For fully automated interpretation of the mass spectra, the
NCBI protein database and the EST database were searched using the
SEQUEST algorithm.
RESULTS
Anti-p200 autoantibodies belong exclusively to the IgG4
subclass Sera from six patients with anti-p200 pemphigoid
were assessed for IgG subclass distribution of p200-speci¢c
autoantibodies. Representative results of this analysis are shown
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in Fig 1. In all six sera anti-p200 reactivity was mediated by IgG4
autoantibodies. Only one serum demonstrated weak additional
IgG1 and IgG2 reactivity.
E⁄cient extraction of p200 occurs only after reduction of
disul¢de bonds and the extracted protein is insoluble in
nonurea bu¡ers As shown in Fig 2(A), under nonreducing
conditions, a bu¡er containing 8 M urea can solubilize only a
trace amount of p200, whereas after incubation with 4 M urea,
no extractable protein can be detected by immunoblotting. In
contrast, reduction of disul¢de bonds with b-mercaptoethanol
enables signi¢cant amounts of p200 to be solubilized by both
urea concentrations. Pretreatment of the dermis with bacterial
collagenase fails to improve the extractability of p200 under
nonreducing conditions. The solubility of p200 obtained by
extraction with 8 M urea plus b-mercaptoethanol was deter-
mined in decreasing concentrations of urea, a urea-free bu¡er
containing a mixture of three detergents (RIPA), and a high-salt
bu¡er without urea or detergents (TBS). The results of this
analysis are presented in Fig 2(B). Reduction of the urea concen-
tration by 50% caused roughly 50% of p200 to precipitate.
Approximately 60% of originally extracted protein remained
soluble in 4 M, 20% in 2 M, and 10% in 1 M urea. p200 was
completely insoluble in nonurea bu¡ers. Addition of detergents
did not improve the solubility of the protein.
p200 is not produced by human keratinocytes or ¢broblasts
in mono- or coculture Total cellular extracts and concentrated
conditioned medium of both cultured human keratinocytes and
¢broblasts were separated by SDS-PAGE and studied by
immunoblotting. The results of this analysis are presented in Fig
2(C). Although cultured cells were demonstrated to produce
various basement membrane proteins, including BP180, the
unprocessed (200-kDa) and processed (165-kDa) forms of the a3
chain of laminin 5, and typeVII collagen, sera from patients with
anti-p200 pemphigoid did not react with any protein derived
from the cellular extract or medium. To investigate the possi-
bility that p200 requires the presence of both keratinocytes and
¢broblasts for its expression in vitro, organotypic cocultures of
human keratinocytes and ¢broblasts were studied by indirect
immuno£uorescence microscopy using p200-speci¢c sera.While
type VII collagen was revealed as continuous lining at the
epithelial^mesenchymal junction of cocultures, no deposition of
p200 was detected (Fig 2D).
P200 is a noncollagenous protein of the DEJ To determine
whether p200 is a member of the collagen family, dermal
extracts were digested with bacterial collagenase and assayed for
reactivity with sera from patients with anti-p200 pemphigoid
and monoclonal antibody LH7.2 against human type VII
collagen. Even prolonged incubation with bacterial collagenase
did not result in degradation of p200 (Fig 3). In contrast, full-
length type VII collagen (290 kDa) was digested to its
collagenase-resistant NC1 domain (145 kDa) within 1 h of
collagenase treatment. With longer incubation times, the
145-kDa band increased in sharpness but was not degraded
any further, con¢rming the speci¢city of collagenolytic activity.
Similar results were obtained using dermal type I and type VI
collagens visualized by immunoblotting with speci¢c rabbit
antisera as controls (not shown). When dermal extracts were
incubated at 371C without collagenase, p200 and type VII
collagen remained intact, as did bovine serum albumin
subjected to collagenase digestion. Treatment of dermal extracts
with bacterial protease V8 resulted in complete loss of p200
reactivity within 30 min after addition of the protease. No
immunoreactive fragments could be detected even after
Figure1. The autoimmune response in anti-p200 pemphigoid is
mediated by IgG4 antibodies. Dermal extracts were separated by SDS-
PAGE and studied by immunoblotting using serum from three patients
with anti-p200 pemphigoid (A^C, respectively) and secondary monoclo-
nal antibodies against human IgG1-IgG4 (strips 1^4 of each panel, respec-
tively). Molecular weight markers (kDa) are indicated on the left.
Figure 2. (A) E⁄cient extraction of p200 is reduction-dependent;
(B) P200 is insoluble in nonurea bu¡ers; (C) P200 is not produced
by human keratinocytes or ¢broblasts in culture; and (D) P200 is
not expressed in organotypic coculture of human keratinocytes
and ¢broblasts. (A) Human dermis was extracted with 8 M urea (8 M),
4 M urea (4 M), or 8 M urea preceded by collagenase digestion (8 M Col)
with (þ ) or without (^) addition of b-mercaptoethanol. Extracts were se-
parated by SDS-PAGE and studied by immunoblotting using serum sam-
ples from patients with anti-p200 pemphigoid. Molecular weight markers
are indicated on the left. (B) Dermal extracts, obtained by extraction with 8
M urea under reducing conditions (Ex) were dialyzed against 4, 2, or 1 M
urea; RIPA bu¡er; or Tris-bu¡ered saline (TBS) and centrifuged at
100,000 g; supernatants (S) and pellets (P) were assessed for the presence
of p200 by immunoblotting. (C) Monoclonal antibody 1A8c recognizes
BP180 in total cellular extracts of human keratinocytes (KE) whereas
monoclonal antibody BM515 stains both the unprocessed (200 kDa) and
the processed (165 kDa) a3 chain of laminin 5 in concentrated conditioned
medium (KM) from HaCaTcells. Monoclonal antibody LH7.2 detects type
VII collagen in both total cellular extracts (FE) and medium (FM) of cul-
tured human ¢broblasts. P200-speci¢c sera samples (ap200) are unreactive
with these substrates. (D) Whereas the monoclonal antibody LH7.2 de-
monstrates continuous deposition of type VII collagen along the epithe-
lial^mesenchymal junction (top), no expression of the p200 antigen is
detected after 3 wk of coculture (bottom). E, epidermis; D, dermis.
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separation of digestion products in a 4% to 20% gradient gel (not
shown).
p200 is an N-linked glycoprotein N-Glycosidase F (PNGase)
is capable of selectively removing all classes of asparagine-bound
glycans from the protein backbone (Tarentino and Plummer,
1987). Incubation of dermal extracts with N-glycosidase F
resulted in an increase of electrophoretic mobility of the p200
autoantigen (Fig 4, left). The deglycosylated protein migrated
almost exactly midway between the intact p200 in dermal
extracts and BP180 recognized by rabbit serum SA8010 in
extracts of cultured human keratinocytes (not shown). There-
fore, the extent of N-glycosylation of p200 was estimated
at approximately 10 kDa. Negative controls incubated without
enzyme did not show any nonspeci¢c degradation of p200,
whereas digestion of bovine fetuin and human transferrin
resulted in reduction of their apparent molecular weights to the
expected sizes of N-deglycosylated proteins.
p200 is not O-glycosylated and is devoid of chondroitin
sulfate and heparan sulfate side chains The most common
O-linked structure found in glycoproteins is Gal-b-1,3 GalNAc
that can be successfully removed by O-glycosidase (Endo and
Kobata, 1976). Nevertheless, modi¢cation of this core structure,
usually by sialylation, can block the action of the enzyme and
needs to be removed by a suitable neuraminidase (sialidase).
Therefore, to investigate the presence of O-linked oligo-
saccharides on the polypeptide backbone of p200, dermal
extracts were sequentially treated ¢rst with neuraminidase and
then with O-glycosidase. This treatment did not result in a
reduction of apparent molecular weight of the p200 molecule,
whereas bovine fetuin showed an expected increase in
electrophoretic mobility after each deglycosylation step (Fig 4,
right). Hence, sialic acid and O-glycans appear to be absent in
p200. For further characterization of the glycosylation status of
p200, dermal extracts were treated with bacterial chondroitinase
ABC and heparitinase I. After digestion with chondroitinase,
no shift in electrophoretic mobility of p200 was observed.
In contrast, proteoglycan I (biglycan), also present in dermal
extract, was e⁄ciently degraded to its 47-kDa core protein as
detected by immunoblotting with a biglycan-speci¢c rabbit
antibody. Similarly, heparitinase I had no e¡ect on the apparent
molecular weight of the p200 molecule, while it rapidly
hydrolyzed bovine heparan sulfate as evidenced by an increased
adsorption at 232 nm (not shown).
All p200 sera target an identical dermal protein To
demonstrate that all six anti-p200 sera bind the same molecule,
we electrophoresed extracts of normal human dermis in two
dimensions (isoelectric focusing followed by SDS-PAGE).
Separated proteins were transferred to nitrocellulose for immuno-
peroxidase staining. Figure 5 shows that di¡erent p200 sera
identify the same major acidic spot at pI 5.4 to 5.6 and molecular
weight of 200 kDa. The spots recognized by di¡erent patient sera
comigrate with each other and with the 200-kDa protein stained
by the same sera in dermal extracts separated only by SDS-PAGE.
Normal human sera did not label this spot.
N-terminal sequencing and mass spectrometry analysis of
the immunoreactive spot In an attempt to determine the
sequence of the p200 autoantigen, the immunoreactive spot of
two-dimensionally separated dermal extracts was subjected to
N-terminal sequencing. However, the protein concentration of
the spot proved to be too low for this analysis. Alternatively, the
immunoreactive spot was studied by mass spectrometry directly
coupled to a nano-HPLC system. Mass spectrometry repeatedly
identi¢ed the a3 chain of type VI collagen and ¢lamin A as the
major components of the spot. No other proteins could be
detected even when using 10-fold concentrated dermal extract
and narrow range high-resolution ampholines for isoelectric
focusing. To determine whether p200 is identical to type VI
collagen or ¢lamin A, puri¢ed human type VI collagen
(Rockland) and recombinant full-length human ¢lamin A (gift
of J.H. Hartwig, Boston, MA) were studied by immunoblotting
using serum from patients with anti-p200 pemphigoid. However,
all patients’ sera were unreactive with both proteins (not shown).
DISCUSSION
The cutaneous basement membrane is a complex network of in-
terconnecting proteins, including the extracellular domains of
Figure 3. p200 is a noncollagenous protein. Dermal extract was di-
gested with bacterial collagenase as described in the text. Extract before
digestion (0 h), after digestion [(1 h (þ ), 16 h (þ )], and control extract in-
cubated without collagenase at 371C for 16 h (16 h (^)) were assayed for
immunoreactivity with serum from patients with anti-p200 pemphigoid
(ap200) and monoclonal antibody against typeVII collagen (LH7.2).Arrow,
full-length typeVII collagen (290 kDa); arrowhead, NC1 domain of typeVII
collagen (145 kDa).
Figure 4. p200 is an N-linked glycoprotein. (Left) N-glycosylation stu-
dies: Dermal extract (DE) was digested with N-glycosidase F (NG). Extract
before digestion (0 h), after digestion (12 h; þ ), and control extract incu-
bated without glycosidase (12 h; ^) were separated by SDS-PAGE and ana-
lyzed for immunoreactivity with serum from patients with anti-p200
pemphigoid. (Right) Sialylation and O-glycosylation studies: Dermal ex-
tract (DE) and bovine fetuin were digested ¢rst with neuraminidase (NA)
and then with O-glycosidase (OG). The p200 autoantigen was visualized
by immunoblotting and fetuin by Coomassie blue staining. þ , with en-
zyme; ^, without enzyme. Incubation periods are indicated below the
respective strips.
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BP180 and a6b4 integrin; laminins 1, 5, and 6; nidogen; type IV
andVII collagen; ¢bronectin; and perlecan (Burgeson and Chris-
tiano, 1997). Interestingly, none of these proteins appears to be
identical to the p200 autoantigen. In contrast to anti-p200 antibo-
dies, those against BP180 and a6b4 integrin stain the epidermal
side of salt-split skin (Tyagi et al, 1996; Sitaru et al, 2002). p200-
speci¢c sera do not react with puri¢ed laminins 1, 5, and 6 (Zilli-
kens et al, 1996; Kawahara et al, 2000) and show linear staining of
the basement membrane by indirect immuno£uorescence micro-
scopy of laminin 5-de¢cient human skin (Zillikens et al, 2000). In
addition, by immunoblotting, monoclonal antibodies BM515
and A1 against the a3 chain of laminin 5 and the g1 chain of la-
minin 1, respectively, do not label the same protein in dermal ex-
tracts compared to p200-speci¢c autoantibodies. Nidogen can be
excluded as a candidate owing to its molecular weight of 80 kDa
(Timpl et al, 1983). In this study, we show that p200 is resistant to
digestion with collagenase, heparitinase, and chondroitinase, thus
eliminating type IV andVII collagen, perlecan, and other proteo-
glycans as possible targets of p200-speci¢c autoantibodies. More-
over, monoclonal antibody LH7.2 against type VII collagen does
not recognize a 200-kDa protein in dermal extracts. Finally, we
determined that anti-p200 sera do not react with puri¢ed human
¢bronectin. Taken together, these data suggest that p200 may re-
present a hitherto unknown component of the cutaneous base-
ment membrane.
IgG4 was demonstrated to be the dominant autoantibody sub-
class in many autoimmune blistering skin diseases, including
pemphigus, BP, mucous membrane pemphigoid, and epidermo-
lysis bullosa acquisita (Yamada et al, 1989; Bernard et al, 1990, 1991;
D˛pp et al, 2000). However, in most patients with these diseases,
the predominance of IgG4 is not absolute and other subclasses are
also encountered in the majority of cases. Interestingly, in patients
with anti-p200 pemphigoid, p200-speci¢c reactivity was mediated
exclusively by IgG4. Such stringent isotype restriction presents an
important advantage for any studies on the p200 autoantigen, as a
monoclonal IgG4-speci¢c secondary antibody can be used for its
immunodetection.
In the past, di¡erential extraction experiments have been suc-
cessfully employed in de¢ning components and organization of
the ECM. In our study, a two-step extraction protocol was used.
In the ¢rst step, human dermis was extracted with 8 M urea
without addition of a reducing agent. Such treatment is known
to solubilize proteins noncovalently associated with the ECM
(Carter, 1982). In the second step, ECM components stabilized
by intermolecular disul¢de bonds were extracted with 8 M urea
plus mercaptoethanol. The p200 autoantigen resisted extraction
by 8 M urea alone but was readily released from the dermis once
disul¢de bonds were disrupted. These ¢ndings suggest that p200
molecules form highly insoluble S-S-dependent complexes.
These complexes may represent homomultimers of p200, similar
to those described for type VII collagen (Bentz et al, 1983; Morris
et al, 1986). Alternatively, p200 may be anchored to (an)other
poorly soluble component(s) of the ECM. Examples of such
covalent protein^protein interactions have been described be-
tween desmogleins and plakoglobin (Eyre and Stanley, 1988) as
well as between laminins 5 and 6/7 (Champliaud et al, 1996). Col-
lagenase digestion of the dermis did not increase the yield of
p200 under nonreducing conditions. Assuming that p200 is in-
deed a part of a heterocomplex stabilized by disul¢de bonding,
this observation suggests that collagenous proteins are not in-
volved in its formation.
To determine whether p200 can be maintained in solution un-
der milder conditions than those required for its initial extrac-
tion, dermal extracts were dialyzed against decreasing con-
centrations of urea, a combination of detergents, and a high-salt
bu¡er without urea or detergents. Minor amounts of p200 re-
mained soluble in the presence of low urea concentrations,
whereas removal of urea resulted in complete precipitation of
the protein. These results should be important for the further
characterization of p200 because they virtually preclude the use
of ¢rst choice techniques such as immunoprecipitation or immu-
noa⁄nity chromatography for its isolation.
To determine the cellular origin of the p200 autoantigen and
to identify a source of the protein soluble in nonurea bu¡ers, we
examined total cellular extracts and concentrated conditioned
medium of both human keratinocytes and ¢broblasts for the pre-
sence of p200. In addition, we studied the reactivity of sera from
patients with anti-p200 pemphigoid with organotypic cocultures
of keratinocytes and ¢broblasts. These cocultures have previously
Figure 5. All patients with anti-p200 pemphigoid recognize an
identical protein of two-dimensionally separated dermal extracts.
Proteins in extracts of normal human dermis were separated by isoelectric
focusing (IEF) in the horizontal dimension and then by SDS-PAGE in the
vertical dimension (thin downward arrow). Control extracts were separated in
the same gels only by SDS-PAGE (thick downward arrow). Proteins were
transferred to nitrocellulose sheets and either probed by sera from three
di¡erent patients with anti-p200 pemphigoid (a^c) or stained with Fast
Green (d). Note that immunoreactive spots in a^c comigrate with each
other at pI 5.4 to 5.6 and with the 200-kDa immunoreactive bands of con-
trol extracts. Migration positions of pI markers are indicated along the
upper margin, and those of molecular weight markers along the right
margin.
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been demonstrated to deposit a well-organized basement mem-
brane in vitro, containing laminins 1 and 5, nidogen, and type IV
and type VII collagen (Smola et al, 1998). Unfortunately, p200-
speci¢c sera did not react with these substrates. It is therefore
likely that conditions required for deposition of p200 in vivo are
not correctly reproduced in mono- and coculture of cutaneous
cells.
Various collagen types have been implicated in human autoim-
mune blistering diseases. TypeVII collagen is a well-characterized
autoantigen of epidermolysis bullosa acquisita, type XVII col-
lagen/BP180 is the common autoantigen in di¡erent pemphigoid
diseases, and the a5 chain of type IV collagen has been recently
described as the antigenic target in patients with a novel autoim-
mune subepidermal blistering disease (Woodley et al, 1984; Gho-
hestani et al, 2000; Zillikens, 2002). Interestingly, we found p200
to be highly resistant to digestion with bacterial collagenase,
whereas major dermal collagens (types I, VI, and VII) were e⁄-
ciently degraded by the enzyme.This result strongly suggests that
p200 is a noncollagenous protein and con¢rms our previous data
demonstrating that p200 is distinct from typeVII collagen (Zilli-
kens et al, 2000).
We demonstrate that p200 is a glycoprotein carrying approxi-
mately 10 kDa of N-linked carbohydrates on its polypeptide
backbone. Such extent of glycosylation would indicate a presence
of about three N-linked oligosaccharide branches within the
p200 molecule. Neuraminic acid residues and O-linked glycan
chains appear to be absent from p200 because the glycoprotein is
resistant to digestion with neuraminidase and O-glycosidase.
Desmogleins 1 and 3, BP180, and type IV and type VII collagen
as well as various laminin chains have all been demonstrated to
possess some form of glycosylation (Sage et al, 1979; Stanley et al,
1982;Woodley et al, 1986; Penn et al, 1987; Knibbs et al, 1989; Nishi-
zawa et al, 1993; Pas et al, 1997; Schumann et al, 2000). Although
the biologic functions of carbohydrate moieties are not yet fully
understood, N-glycans of laminin were shown to be important
for cell adhesion and spreading as well as for neurite outgrowth
formation (Dennis et al, 1984; Dean et al, 1990) while unglycosy-
lated type VII collagen could not be secreted by cultured cells
into the medium (Chen et al, 1997). In addition, carbohydrate
antigenic determinants were demonstrated to be important for
autoantibody response in several diseases, including pernicious
anemia, chronic Chagas’ disease, rheumatoid arthritis, and endo-
metriosis (Goldkorn et al, 1989; Almeida et al, 1994; Blass et al,
1998; Lang andYeaman, 2001). Removal of asparagine-linked oli-
gosaccharides from p200 did not a¡ect antigen recognition by
patients’ autoantibodies, indicating that its epitopes are glycosyla-
tion-independent. Interestingly, the same is true for antigenic
determinants recognized by pemphigus autoantibodies on
desmogleins 1 and 3 and BP-speci¢c epitopes on BP180 (Amagai
et al, 1995; Pas et al, 1997; Schumann et al, 2000).
Since its ¢rst description in 1996, 14 cases of anti-p200 pemphi-
goid have been published (reviewed in Watanabe et al, 2002).
Although antibodies in sera of all these patients recognized a der-
mal protein of 200 kDa by immunoblotting, certain dissimilari-
ties in clinical presentation, histopathologic ¢ndings, and
response to treatment raised questions with regard to the com-
mon identity of the target molecule in these patients. In addition,
some degree of heterogeneity in the apparent molecular weight
of the 200-kDa antigen was reported (Mascaro et al, 2000). In this
study, we demonstrate that as many as six patients with anti-p200
pemphigoid recognize an identical dermal protein as de¢ned by
molecular weight, isoelectric point, collagenase resistance, and
extent of glycosylation. These ¢ndings strongly suggest that
anti-p200 pemphigoid forms a single entity characterized by an
autoimmune response against a unique component of the cuta-
neous basement membrane.
In an attempt to determine the amino acid sequence of the
p200 autoantigen, the immunoreactive spot of two-dimension-
ally separated dermal extracts was studied by Edman degradation
and mass spectrometry. Although the protein concentration of
the spot proved to be too low for N-terminal sequencing, mass
spectrometry identi¢ed the a3 chain of typeVI collagen and ¢la-
min A. Type VI collagen is a ubiquitous collagenous heterotri-
meric protein composed of a1 and a2 chains, each of 140 kDa,
and an a3 chain of 200 kDa (Trˇeb and Winterhalter, 1986). In
the skin, type VI collagen is produced by dermal ¢broblasts and
deposited throughout the reticular and papillary dermis as de-
tected by indirect immuno£uorescence microscopy (Hessle and
Engvall, 1984). Immunoelectron microscopic studies demon-
strated that dermal type VI collagen forms a micro¢brillar net-
work closely associated with interstitial collagen but does not
localize to the cutaneous basement membrane or anchoring pla-
ques (Keene et al, 1988). Filamin A is a 250-kDa cytoskeletal pro-
tein of smooth muscle and nonmuscle cells (Wang et al, 1975). In
the skin, ¢lamin is expressed in the peripheral cytoplasm of ker-
atinocytes and is not present in the ECM (Kubler andWatt, 1993).
Thus, biochemical properties and ultrastructural localization of
type VI collagen and ¢lamin A are quite di¡erent from those of
p200, a noncollagenous protein of the cutaneous basement mem-
brane. In fact, sera from patients with anti-p200 pemphigoid did
not react with puri¢ed type VI collagen or recombinant full-
length ¢lamin A. The ¢nding that all p200-speci¢c sera unequi-
vocally recognize the same spot of two-dimensionally separated
dermal extracts but remain unreactive with its identi¢able com-
ponents raises two possibilities: (1) autoantibodies from patients
with anti-p200 pemphigoid may recognize unique epitope(s)
not present within full-length type VI collagen or ¢lamin A. In
fact, most sera samples from patients with linear IgA disease react
with cleavage-derived neoepitopes on the LABD97 and LAD-1
autoantigens but not with the full-length BP180 molecule (Zone
et al, 1990; Pas et al, 1997; Schumann et al, 2000). (2) Another pro-
tein, distinct from both type VI collagen and ¢lamin A, may be
present within the immunoreactive spot.This protein may not be
detected by mass spectrometry owing to its low concentration or
owing to the absence of its sequence from the available databases.
The experimental evidence presented above rather supports the
latter possibility. Owing to the limits imposed by poor solubility
of dermal proteins, we were unable to concentrate dermal extract
by more than a factor of 10. Our attempts to purify p200 by a
combination of collagenase digestion and ion-exchange chroma-
tography resulted in too much loss of immunoreactive protein.
The enrichment of dermal extract for p200 may therefore be in-
su⁄cient to identify the protein using a purely biochemical ap-
proach. Our future e¡orts will be directed at screening a human
skin cDNA library with p200-speci¢c autoantibodies. After ini-
tial library screens, the new insights into the biochemistry of this
autoantigen, provided by the present study, should be helpful for
the selection of proteins warranting further investigation.
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